Stergiou Angelos M.
SEC insider (Form 3/4/5 filer). CIK 0001724253. President and CEO at SELLAS Life Sciences Group, Inc. (SLS). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in NEW YORK, NY.
Companies Stergiou Angelos M. has filed insider reports for
- SELLAS Life Sciences Group, Inc. (SLS): Director, Officer, President and CEO
Stergiou Angelos M.
CIK: 0001724253
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SELLAS Life Sciences Group, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 16, 2026SLS
SELLAS Life Sciences Group, Inc.
AwardDirect1.1M shares- - Dec 3, 2025SLS
SELLAS Life Sciences Group, Inc.
OtherDirect187.1K shares at avg. $1.50$281K - Jan 10, 2025SLS
SELLAS Life Sciences Group, Inc.
AwardDirect257K shares- - Jan 10, 2025SLS
SELLAS Life Sciences Group, Inc.
AwardDirect243.9K shares- - Dec 4, 2024SLS
SELLAS Life Sciences Group, Inc.
OtherDirect28.3K shares at avg. $1.13$32K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 | SLS SELLAS Life Sciences Group, Inc. | Award | 1,065,000 | - | $0 | Direct |
| Dec 3, 2025 | SLS SELLAS Life Sciences Group, Inc. | Other | 187,066 | $1.50 | $280,599 | Direct |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | Award | 257,000 | - | $0 | Direct |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | Award | 243,900 | - | $0 | Direct |
| Dec 4, 2024 | SLS SELLAS Life Sciences Group, Inc. | Other | 28,289 | $1.13 | $31,967 | Direct |
1-5 of 5 transactions